Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism
about
Genetic Risk Factors for Ischemic and Hemorrhagic StrokeThe European Hematology Association Roadmap for European Hematology Research: a consensus documentHeart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationSingle nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosisComparison of HapMap and 1000 Genomes Reference Panels in a Large-Scale Genome-Wide Association Study.Single Nucleotide Variant rs2232710 in the Protein Z-Dependent Protease Inhibitor (ZPI, SERPINA10) Gene Is Not Associated with Deep Vein Thrombosis.Dissecting the genetic determinants of hemostasis and thrombosisA comprehensive survey of genetic variation in 20,691 subjects from four large cohorts.Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).Novel genetic predictors of venous thromboembolism risk in African Americans.The association of statin therapy with the risk of recurrent venous thrombosis.Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins: The Tromsø Study.Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism.Thrombosis Related ABO, F5, MTHFR, and FGG Gene Polymorphisms in Morbidly Obese Patients.Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk.Sensitized mutagenesis screen in Factor V Leiden mice identifies thrombosis suppressor loci.Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels.Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study.Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.Genome-wide association study with additional genetic and post-transcriptional analyses reveals novel regulators of plasma factor XI levels.Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect.Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor.Identification of Genetic Variants Linking Protein C and Lipoprotein Metabolism: The ARIC Study (Atherosclerosis Risk in Communities).Is there still room for additional common susceptibility alleles for venous thromboembolism?SLC44A2 single nucleotide polymorphisms, isoforms, and expression: Association with severity of Meniere's disease?Whole exome sequencing in thrombophilic pedigrees to identify genetic risk factors for venous thromboembolism.Regulation of plasma von Willebrand factor.Recurrent mutations in a SERPINC1 hotspot associate with venous thrombosis without apparent antithrombin deficiency.The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants.Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study.Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism.Identification of unique venous thromboembolism-susceptibility variants in African-Americans.Failure to replicate thrombomodulin genetic variant predictors of venous thromboembolism in African Americans.Thrombophilia Screening: Universal, Selected, or Neither?Whole Exome Sequencing Identifies New Host Genomic Susceptibility Factors in Empyema Caused by Streptococcus pneumoniae in Children: A Pilot Study.Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomicsWhat is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologiesCase-control studies of gene-environment interactions. When a case might not be the case
P2860
Q28079249-F7FBFA36-234E-44E1-B506-D11009271332Q28830861-91471754-94B5-4FD2-BB1C-8C89C4C13A91Q30238784-E8DBCB0F-18ED-4BD2-A3A7-D24C404B4D68Q30275601-4F603E0F-558E-4787-A0BE-008FCE392F76Q30277281-F61B1CD2-7035-4FC6-85F4-D840D7591278Q30490746-53E2F636-0438-4D5B-99FC-43F754A39C5EQ35959692-6164C2DC-8C92-4E45-B0AB-E875B49314D9Q36259417-31D60D1F-29C6-443F-B3CC-47C9F6AC3192Q36310685-04B19A3F-27E2-4FFB-9D20-E015F0E840B1Q36625170-1492161E-9F89-49EF-8C1B-A5F3E49D6E8BQ36800467-2A2CCB47-5B06-47E2-A853-21018179F179Q37138335-C4D3A367-D1E5-40FA-ABEF-3391E7E9C04BQ37170991-5336E4AF-53FC-44F7-B413-264692457C1AQ37331210-9CF1593C-2184-4056-AFC9-265320F8936CQ37479952-B6A147BB-6F8A-4F3B-8BAD-025AF86EF328Q37736739-A8F086CA-DC4C-48E5-ACF8-E570EFEAC30BQ38615493-EDCF7A3C-714F-4379-A940-75E643248849Q38728512-E636221F-EEA5-4BB3-9796-3AFD4B4B4937Q38772826-AEB48EB3-6209-4B50-AF68-CA749219180CQ38986410-C30D70E7-6FF9-40B3-A44D-0CC51AA29371Q39040002-ED8ECA16-F51D-4AE4-BCA7-D318E74886A7Q39743484-507E3D82-780A-4DD9-8098-6D48AF5D546FQ40260213-C936C955-0DAC-4567-85F9-506350822A04Q40383043-511934A7-2562-40FB-B143-0E4199A2CDDDQ40689903-B57D912D-ED7E-4142-8670-73462449CC84Q45841635-E0FCD949-BDF8-4668-A910-8DCEBDD1C893Q47120217-EEF1EE34-A05C-4632-9640-398A8382A817Q49246959-8C74B07A-86B1-4A79-8179-7CC9174E0130Q49252439-73FCDA99-5C7E-4DDC-B20F-285C0C08D2B9Q50199930-0E72C355-7BF9-4729-908E-E25FB605B806Q50531000-CA06970F-8DE4-42F3-9F19-09BFD8C0B137Q51642246-ED5ACD41-8051-4171-9714-2AC125526869Q53080453-46A58BEE-0C18-491E-9C67-32C04DA52DE3Q53502586-D6C7912E-FD18-4D82-B87A-CEECA492D8B7Q53727531-992DE004-CBEA-4EB3-B292-A7DD5CF2FC76Q53812184-BD06A283-D636-42DC-80B9-1457CA95CA09Q55284920-14EA535C-9C46-4635-BAAC-4ECE68E83366Q57165119-362EFBB6-8430-4C0D-B59C-5172DC024023Q57611689-9D76121F-5A75-46AC-A3B1-47EB88D05D74Q58723324-BABD4E4A-E9AC-41AF-B7D6-CAB1807B7312
P2860
Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Meta-analysis of 65,734 indivi ...... oci for venous thromboembolism
@ast
Meta-analysis of 65,734 indivi ...... oci for venous thromboembolism
@en
type
label
Meta-analysis of 65,734 indivi ...... oci for venous thromboembolism
@ast
Meta-analysis of 65,734 indivi ...... oci for venous thromboembolism
@en
prefLabel
Meta-analysis of 65,734 indivi ...... oci for venous thromboembolism
@ast
Meta-analysis of 65,734 indivi ...... oci for venous thromboembolism
@en
P2093
P2860
P50
P1476
Meta-analysis of 65,734 indivi ...... oci for venous thromboembolism
@en
P2093
Antonio Di Narzo
Ares Rocanin-Arjo
Astrid van Hylckama Vlieg
Cardiogenics Consortium
Claudine Berr
Daniel I Chasman
Eline Slagboom
France Gagnon
François Cambien
Frits R Rosendaal
P2860
P304
P356
10.1016/J.AJHG.2015.01.019
P407
P50
P577
2015-03-12T00:00:00Z